Key Events This Week
21 Sep: Lower circuit hit amid heavy selling pressure (Rs.5.47)
22 Sep: Continued lower circuit hit with intensified selling (Rs.5.37)
23 Sep: Upper circuit triggered on strong buying interest (Rs.5.46)
24 Sep: Upper circuit again amid robust demand despite regulatory freeze (Rs.5.45)
25 Sep: Week closes with lower circuit hit amid renewed selling (Rs.5.50)
21 September: Lower Circuit Hit Amid Heavy Selling Pressure
Vivimed Labs opened the week under significant pressure, hitting its lower circuit band at Rs.5.47, a 1.25% decline from the previous close. The stock’s price fluctuated between Rs.5.65 and Rs.5.47, but selling interest overwhelmed buyers, capping losses at the circuit limit. Trading volume was subdued at approximately 41,350 shares, reflecting limited liquidity typical of micro-cap stocks. Despite the broader Sensex rising 0.46%, Vivimed Labs’ decline highlighted company-specific weakness and investor anxiety.
Technically, the stock remained below all key moving averages, confirming a bearish trend. Delivery volumes had plummeted sharply in prior sessions, signalling waning genuine investor interest and increased speculative activity. The MarketsMOJO Mojo Score stood at 17.0 with a Strong Sell rating, reflecting deteriorating fundamentals and heightened risk.
22 September: Continued Lower Circuit Amid Intensified Selling
The downtrend intensified as Vivimed Labs again hit the lower circuit at Rs.5.37, losing 1.83% on the day. The stock underperformed both its sector and the Sensex, which declined marginally by 0.32%. Trading volumes remained low at 26,460 shares, underscoring persistent liquidity challenges. Despite the price fall, delivery volumes surged by over 950% compared to the five-day average, suggesting some investors were offloading holdings amid panic or repositioning.
The stock’s 11-day losing streak and trading below all major moving averages reinforced the bearish technical outlook. The micro-cap status and erratic trading patterns further exacerbated volatility. The Strong Sell Mojo Grade was reaffirmed, signalling caution amid ongoing negative momentum.
From struggle to strength! This Small Cap from Textile - Machinery is showing early turnaround signals that look promising. Position yourself now for explosive growth potential ahead!
- - Early turnaround signals
- - Explosive growth potential
- - Textile - Machinery recovery play
23 September: Upper Circuit Triggered on Strong Buying Pressure
In a notable reversal, Vivimed Labs hit its upper circuit band at Rs.5.46, gaining 1.49% and outperforming the Pharmaceuticals & Drugs sector’s 0.25% gain and the Sensex’s 0.56% rise. The stock traded between Rs.5.29 and Rs.5.48, closing near the upper price limit amid robust demand. However, trading volumes remained modest at 28,610 shares, reflecting the micro-cap’s liquidity constraints.
Investor participation improved, with delivery volumes increasing by over 80% compared to the five-day average, indicating a shift towards holding rather than intraday trading. Despite this short-term optimism, the stock remained below all key moving averages, signalling that the broader downtrend persisted. The regulatory freeze triggered by the upper circuit limited further price appreciation and left significant buy orders unfilled, highlighting latent demand but also the stock’s volatility.
24 September: Upper Circuit Again Amid Intense Buying Despite Regulatory Freeze
Vivimed Labs continued its brief rally, hitting the upper circuit at Rs.5.46 again, closing at Rs.5.45 with a 1.68% gain. This outperformance contrasted with the Pharmaceuticals & Drugs sector’s modest 0.13% gain and the Sensex’s 0.96% decline. Intraday prices ranged from Rs.5.34 to Rs.5.46, with total traded volume of 63,900 shares. The regulatory freeze on further trades persisted, leaving many buy orders unexecuted and underscoring strong demand despite limited liquidity.
Technically, the stock remained below all major moving averages, indicating the rally was likely driven by short-term speculative interest rather than a sustained uptrend. Delivery volumes dropped sharply by nearly 99%, suggesting reduced investor commitment to holding shares amid the price surge. The Mojo Score remained at 12.0 with a Strong Sell grade, reflecting ongoing fundamental concerns.
Vivimed Labs Ltd or something better? Our SwitchER feature analyzes this micro-cap stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
25 September: Week Closes with Lower Circuit Amid Renewed Selling
The week ended on a bearish note as Vivimed Labs hit the lower circuit at Rs.5.50, down 1.69%. The stock’s price fluctuated between Rs.5.35 and Rs.5.50 but could not recover above the circuit limit due to persistent selling pressure. Trading volume was extremely low at 7,350 shares, reflecting dwindling investor participation. Delivery volumes had dropped by over 70% compared to the five-day average, signalling weak demand and heightened risk aversion.
Despite outperforming its sector by 1.26% on the day, the stock’s technical position remained weak, trading below all key moving averages and maintaining a Strong Sell Mojo Grade of 12.0. The micro-cap status and limited liquidity continue to expose the stock to sharp price swings and panic selling. The unfilled supply at lower price levels has created a bottleneck, preventing price recovery and reinforcing the downtrend.
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-09-21 | Rs.5.62 | -1.92% | 35,787.64 | +0.46% |
| 2026-09-22 | Rs.5.51 | -1.96% | 35,672.04 | -0.32% |
| 2026-09-23 | Rs.5.40 | -2.00% | 35,870.78 | +0.56% |
| 2026-09-24 | Rs.5.32 | -1.48% | 35,291.38 | -1.62% |
| 2026-09-25 | Rs.5.42 | +1.88% | 35,353.29 | +0.18% |
Key Takeaways
The week’s price action for Vivimed Labs Ltd was dominated by extreme volatility and circuit hits, reflecting a fragile balance between selling pressure and intermittent buying interest. The stock’s 5.41% weekly decline significantly outpaced the Sensex’s 0.76% fall, underscoring company-specific challenges.
Persistent trading below all major moving averages and a Strong Sell Mojo Grade of 12.0 highlight the weak technical and fundamental backdrop. The micro-cap status and limited liquidity exacerbate price swings, with even modest orders triggering circuit limits. Delivery volumes fluctuated sharply, indicating inconsistent investor commitment and speculative trading.
Despite brief upper circuit hits on 23 and 24 September signalling short-term buying enthusiasm, the inability to sustain gains and repeated lower circuit hits on 21, 22, and 25 September confirm the prevailing bearish sentiment. Regulatory freezes during upper circuit events further constrained price discovery and liquidity.
Sector performance was relatively stable compared to Vivimed Labs’ sharp moves, suggesting that the stock’s volatility is largely idiosyncratic. Investors should remain cautious given the deteriorating fundamentals, technical weakness, and micro-cap risks.
Conclusion
Vivimed Labs Ltd’s week was characterised by sharp swings between lower and upper circuit hits, reflecting a stock caught in a volatile downtrend with intermittent speculative interest. The 5.41% weekly decline against a modest Sensex fall highlights the stock’s vulnerability amid weak fundamentals and limited liquidity. The Strong Sell Mojo Grade and persistent trading below key moving averages reinforce the negative outlook.
While short-term rallies demonstrated pockets of buying demand, the overall trend remains bearish with significant downside risks. The micro-cap nature of Vivimed Labs amplifies price volatility and trading challenges, necessitating a cautious approach. Investors should closely monitor delivery volumes, price action relative to moving averages, and any fundamental developments before considering exposure to this stock.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
